Peek Behind the Paper: the consequences of rising out-of-pocket drugs costs for MS patients

Lead and senior authors Alvaro San-Juan-Rodriguez and Inmaculada Hernandez (both from the University of Pittsburgh, PA, USA) discuss their study paper concerning Medicare and patient spending on multiple sclerosis (MS) disease-modifying therapies. In 2019, we reported on some important research investigating patients’ out-of-pocket, multiple sclerosis (MS) drug coverage payments, which revealed that under Medicare Part D, MS patients have faced a seven-fold increase in personal costs for drugs over the last decade. Now, take the opportunity to revisit this and evaluate how far the field has come in this interview with lead and senior authors Alvaro San-Juan-Rodriguez and Inmaculada Hernandez (both...